• Improved In Vitro Assessment of Cancer Drug Responses

  2026-07-16

  Schwartz's dissertation redefines how drug efficacy is evaluated in vitro by distinguishing between proliferative arrest and cell death, rather than using a single viability metric. This nuanced framework enables more accurate characterization of anti-cancer agents, supporting reliable assay design and translational research.

• Azathramycin A: Strategic Leverage in Tuberculosis Research

  2026-07-16

  This thought-leadership article explores the mechanistic basis and translational impact of Azathramycin A as a next-generation macrolide antibiotic for tuberculosis research. Integrating foundational biochemistry, comparative pharmacology, and actionable guidance, it empowers researchers to navigate drug resistance challenges and optimize experimental design. Featuring protocol recommendations and a balanced outlook, it positions APExBIO’s Azathramycin A as a valuable tool for scientific innovation.

• Firefly Luciferase mRNA: Optimized Workflows and Applied Ins

  2026-07-15

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) delivers robust, low-immunogenicity luminescent reporting for gene expression, cell viability, and in vivo imaging. This guide distills experimental best practices, troubleshooting, and workflow optimizations to help you unlock high-sensitivity, reproducible results in real-world applications.

• 5-Methyl-CTP in mRNA Synthesis: Beyond Stability to Vaccine

  2026-07-15

  Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, advances mRNA synthesis for robust vaccine efficacy, with a focus on practical assay decisions and translational impact. Uncover unique insights into mRNA drug development workflows and real-world applications.

• hly Gene Deletion Weakens Biofilm and Antibiotic Resistance

  2026-07-14

  This study reveals that deleting the hly gene in Listeria monocytogenes impairs biofilm formation and increases susceptibility to ribosome-targeting antibiotics. These findings clarify hly’s central role in biofilm architecture, virulence regulation, and persistence, with implications for controlling foodborne contamination.

• AG-490 (Tyrphostin B42): Translating JAK2/EGFR Inhibition to

  2026-07-14

  This thought-leadership piece explores how AG-490 (Tyrphostin B42) is reshaping translational cancer research by targeting the JAK-STAT and MAPK signaling pathways. Integrating new evidence on exosome-driven macrophage polarization, it provides mechanistic insights, experimental guidance, and strategic outlooks for researchers pursuing next-generation oncological and immunopathological investigations.

• KPT-330 (Selinexor) for Targeted Nuclear Export Blockade in

  2026-07-13

  KPT-330 (Selinexor) offers a selective, orally bioavailable strategy for inhibiting CRM1-mediated nuclear export, enabling precise control over tumor suppressor localization and apoptosis induction in cancer models. Recent insights also highlight its unique dual-action in both cancer and osteoclast-driven diseases, broadening its translational research impact.

• Hexose Diphosphate: Advanced Insights Into Metabolic Regulat

  2026-07-13

  Explore the pivotal role of hexose diphosphate in energy homeostasis research, enzymatic regulation, and inflammation modulation. This in-depth analysis reveals unique applications and mechanistic insights, setting it apart from existing metabolic assay literature.

• Berberine Hydrochloride: Applied Workflows in Gut–Bone Axis

  2026-07-12

  Berberine hydrochloride is transforming osteoimmune and metabolic research, enabling high-fidelity modeling of the gut–bone axis and estrogen-deficiency bone loss. This article provides experimental workflow guidance, troubleshooting strategies, and protocol parameters, anchored in the latest mechanistic breakthroughs and optimized for translational impact.

• SGI-1027 (SKU B1622): Reliable DNA Methyltransferase Inhibit

  2026-07-10

  This evidence-led article explores real laboratory challenges in DNA methylation assays and cancer epigenetics, demonstrating how SGI-1027 (SKU B1622) delivers reproducible, high-quality results. Learn why biomedical scientists rely on this quinoline-based DNA methyltransferase inhibitor for robust gene reactivation, referencing recent peer-reviewed data and practical workflow insights.

• NAT10-Driven ac4C RNA Modification Regulates Oocyte Maturati

  2026-07-09

  The reference study establishes that NAT10-mediated N4-acetylcytidine (ac4C) RNA modification is crucial for post-transcriptional regulation during mouse oocyte maturation in vitro. This work illuminates ac4C’s mechanistic role in meiotic progression and identifies TBL3 as a potential ac4C-binding protein, providing new insights for optimizing oocyte developmental competence.

• CXCL1-CXCR2 Signals Activate NTS Microglia in Pancreatic Can

  2026-07-09

  This study uncovers a central role for CXCL1-CXCR2 signaling in activating microglia within the nucleus tractus solitarii (NTS), thereby promoting pancreatic cancer-induced pain. Targeting this chemokine axis in the NTS reduced pain behaviors and neuroinflammation in preclinical models, highlighting a potential avenue for developing more effective pain therapies in pancreatic cancer.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor for Advance

  2026-07-08

  LY364947 from APExBIO empowers researchers to achieve selective, reproducible inhibition of TGF-β signaling in studies of EMT, fibrosis, and retinal degeneration. Discover optimized workflows, troubleshooting insights, and how recent mechanistic breakthroughs can be translated into robust assay design.

• Causal Roles of CLEC5A and ISG20 in Atherosclerosis Elucidat

  2026-07-08

  Zhang et al. (2025) integrated Mendelian randomization and eQTL analysis to causally implicate CLEC5A and ISG20 in atherosclerosis, revealing their upregulation in disease and mechanistic involvement in macrophage-driven lipid accumulation and inflammation. Experimental validation confirmed ISG20's potential as a therapeutic target, advancing our molecular understanding of atherosclerosis.

• Central Brain-Spinal Circuits in Opioid-Induced Mechanical H

  2026-07-07

  Yin et al. (2024) reveal a central brain-to-spinal opioid pathway that mediates morphine-induced mechanical hypersensitivity and tolerance, distinct from peripheral and thermal mechanisms. These findings highlight new molecular and circuit targets for mitigating opioid-related side effects in pain management.

11491 records 1/767 page Next 12345 下5页 Last page